Somatostatin receptor
6 drugs5
approved indications
6
Approved Drugs
5
Companies
7
Indications
0
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (5 companies)
✓ All 6 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (7 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
WEST-WARD PHARMS INT 2 drugs
Novartis 1 drug
Sun Pharma 1 drug
By Therapeutic Area
Other 6 drugs
Drugs by Company PRO
WEST-WARD PHARMS INT 2 drugs
Novartis 1 drug
Sun Pharma 1 drug
IPSEN PHARMA 1 drug
CHIESI 1 drug
By Therapeutic Area
Other 6 drugs
OCTREOTIDE ACETATE (PRESERVATIVE FREE), SANDOSTATIN LAR, BYNFEZIA PEN, SOMATULINE DEPOT +2 more
Indications Treated
AcromegalyCarcinoid TumorDiarrheaFlushingVasoactive Intestinal Peptide TumorGastroenteropancreatic Neuroendocrine TumorsCarcinoid Syndrome
All Drugs Targeting Somatostatin receptor
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| OCTREOTIDE ACETATE (PRESERVATIVE FREE) | WEST-WARD PHARMS INT | 2005 | 5 | |
| SANDOSTATIN LAR | Novartis | 1998 | 5 | |
| BYNFEZIA PEN | Sun Pharma | 2024 | 5 | |
| SOMATULINE DEPOT | IPSEN PHARMA | 2007 | 3 | |
| MYCAPSSA | CHIESI | 2020 | 1 | |
| OCTREOTIDE ACETATE | WEST-WARD PHARMS INT | 2005 | - |